These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26069766)

  • 1. Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosis.
    Alsabbagh MM; Ejaz AA; Purich DL; Ross EA
    Clin Kidney J; 2012 Jun; 5(3):212-6. PubMed ID: 26069766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation.
    Köglberger P; Klein SJ; Lehner GF; Bellmann R; Peer A; Schwärzler D; Joannidis M
    Ann Intensive Care; 2021 Apr; 11(1):62. PubMed ID: 33891213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report.
    Nalesso F; Stefanelli F; Cattarin L; Billo M; Gnappi M; Partesano G; Cacciapuoti M; Babuin L; Calò LA
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.
    Swartz R; Pasko D; O'Toole J; Starmann B
    Clin Nephrol; 2004 Feb; 61(2):134-43. PubMed ID: 14989634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration.
    Premuzic V; Basic-Jukic N; Jelakovic B; Kes P
    Ther Apher Dial; 2017 Jun; 21(3):279-286. PubMed ID: 28403554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.
    Bunchman TE; Maxvold NJ; Brophy PD
    Am J Kidney Dis; 2003 Dec; 42(6):1248-52. PubMed ID: 14655197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate anticoagulation in pediatric continuous venovenous hemofiltration.
    Elhanan N; Skippen P; Nuthall G; Krahn G; Seear M
    Pediatr Nephrol; 2004 Feb; 19(2):208-12. PubMed ID: 14669096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate anticoagulation during CVVH in high risk bleeding patients.
    Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A
    Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.